Others inject on training days, finding that exercise actually reduces nausea
Causal factors for knee, hip, and hand osteoarthritis: a Mendelian randomization study in the UK biobank
When patients tell their doctors that they have abdominal pain (a common side effect of GLP-1 drugs), and a blood or urine test shows elevated amylase or lipase levels, thats two out of three criteria for pancreatitis, says Drucker
There was no plateau, and in fact it appears longer term trials will probably easily clear 20% weight loss, especially if metformin and/or SGLT2i medications are added on as these can both add another 2-3% extra weight loss when combined with a GLP-1 medication
Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial
It looks like much of the weight that people lose when they take GLP-1 agonists is muscle mass and not necessarily fat mass